These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 16925136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multitargeted agents for therapeutically challenging tumor: an introduction for oncology nurses.
    King CR.
    ONS News; 2006; 21(8 Suppl):57-8. PubMed ID: 16925154
    [No Abstract] [Full Text] [Related]

  • 3. Renal cell carcinoma: the translation of molecular biology into new treatments, new patient outcomes, and nursing implications.
    Moldawer NP, Figlin R.
    Oncol Nurs Forum; 2008 Jul; 35(4):699-708. PubMed ID: 18591174
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [New treatments for renal carcinoma].
    Pérez-Gracia JL, López-Picazo JM, Olier C, Alfaro C, García-Foncillas J, Melero I, Gúrpide A.
    An Sist Sanit Navar; 2007 Jul; 30(3):393-403. PubMed ID: 18227896
    [Abstract] [Full Text] [Related]

  • 6. [Interdisciplinary recommendations on targeted therapy in the treatment of renal cell carcinoma].
    Miller K, Bergmann L, Albers P, Jäger E, Jakse G, Geschwend JE, Marschner N.
    Aktuelle Urol; 2007 Jul; 38(4):328-30. PubMed ID: 17647172
    [Abstract] [Full Text] [Related]

  • 7. Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel.
    Pouessel D, Culine S.
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1761-7. PubMed ID: 17181490
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New therapeutic options for renal cell carcinoma.
    Stadler W.
    Clin Adv Hematol Oncol; 2006 Jun; 4(6):429-30. PubMed ID: 16981664
    [No Abstract] [Full Text] [Related]

  • 12. CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.
    Stein MN, Flaherty KT.
    Clin Cancer Res; 2007 Jul 01; 13(13):3765-70. PubMed ID: 17606705
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic basis of kidney cancer: a model for developing molecular-targeted therapies.
    Vira MA, Novakovic KR, Pinto PA, Linehan WM.
    BJU Int; 2007 May 01; 99(5 Pt B):1223-9. PubMed ID: 17441915
    [No Abstract] [Full Text] [Related]

  • 16. Present state of target therapy for disseminated renal cell carcinoma.
    Waalkes S, Kramer M, Herrmann TR, Schrader AJ, Kuczyk MA, Merseburger AS.
    Immunotherapy; 2010 May 01; 2(3):393-8. PubMed ID: 20635903
    [Abstract] [Full Text] [Related]

  • 17. Two new drugs for renal cell carcinoma.
    Med Lett Drugs Ther; 2007 Feb 26; 49(1255):18-20. PubMed ID: 17325624
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New therapeutic strategies for renal cell carcinoma.
    Wood LS.
    Urol Nurs; 2010 Feb 26; 30(1):40-53. PubMed ID: 20359144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.